Michida, Hiroki
Hagiwara, Asami
Saito, Yuki
Kawasaki, Noriko
Kanda, Mayuka
Kawasaki, Mika
Karakawa, Sachise
Suzuki, Hidetaka
Ikeda, Masafumi
Makinoshima, Hideki
Mitsunaga, Shuichi
Article History
Received: 13 January 2026
Accepted: 2 April 2026
First Online: 12 April 2026
Declaration
:
: H. Michida, A.H., Y.S., N.K., M. Kanda, M. Kawasaki, and S. K. are employed by Ajinomoto Co. Inc. S.M. reports grants from Ajinomoto, Ono Pharmaceutical, and Pfizer Inc. outside the submitted work; lecture fees from Ono Pharmaceutical, Otsuka Pharmaceutical, and Meiji Seika Pharmaceutical outside the submitted work; and a patent for a biomarker using free plasma amino acids to predict sarcopenia outside the submitted work. M.I. reports grants from Boehringer Ingelheim, Delta-Fly Pharma, N.V., Invitrogen, NIHON SERVIER, and Novartis outside the submitted work; consulting fees from Astellas Pharma, Novartis, and NIHON SERVIER outside the submitted work; and lecture fees from Guardant Health Japan, NIHON SERVIER, Taiho, Nippon Kayaku, and Yakult outside the submitted work. The authors declare no other competing interests.